Dr. Lucy Gilbert, MD
Claim this profileMcGill University Health Centre
Expert in Ovarian Cancer
Studies Ovarian Tumors
17 reported clinical trials
29 drugs studied
Area of expertise
1Ovarian Cancer
Global LeaderStage IV
Stage III
FRα positive
2Ovarian Tumors
Stage IV
Stage III
FRα positive
Affiliated Hospitals
Clinical Trials Lucy Gilbert, MD is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
TORL-1-23
for Ovarian Cancer
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer.
Recruiting1 award Phase 25 criteria
More about Lucy Gilbert, MD
Clinical Trial Related5 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Lucy Gilbert, MD has experience with
- Carboplatin
- Paclitaxel
- Mirvetuximab Soravtansine
- Selinexor
- Dostarlimab
- Gemcitabine
Breakdown of trials Lucy Gilbert, MD has run
Ovarian Cancer
Ovarian Tumors
Fallopian Tube Cancer
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lucy Gilbert, MD specialize in?
Lucy Gilbert, MD focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Lucy Gilbert, MD currently recruiting for clinical trials?
Yes, Lucy Gilbert, MD is currently recruiting for 8 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Lucy Gilbert, MD has studied deeply?
Yes, Lucy Gilbert, MD has studied treatments such as Carboplatin, Paclitaxel, Mirvetuximab Soravtansine.
What is the best way to schedule an appointment with Lucy Gilbert, MD?
Apply for one of the trials that Lucy Gilbert, MD is conducting.
What is the office address of Lucy Gilbert, MD?
The office of Lucy Gilbert, MD is located at: McGill University Health Centre, Montreal, Quebec H4A 3J1 Canada. This is the address for their practice at the McGill University Health Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.